Literature DB >> 9493145

Clinical profile of patients with late-onset SLE: not a benign subgroup.

S K Mak1, E K Lam, A K Wong.   

Abstract

The onset of systemic lupus erythematosus (SLE) in later life has been associated with a benign clinical course and better prognosis compared with those with earlier onset. However, different reported studies have failed to agree on a distinct pattern of presentation. We retrospectively studied the clinical profile of a predominantly Chinese lupus population to review the behaviour of late-onset patients. Cumulative clinical features and laboratory findings in 102 patients with SLE were collected. Late-onset patients tended to have a less marked female predominance, a more insidious onset at presentation (P < 0.001), a decreased incidence of cutaneous lesions (P < 0.05), an increased occurrence of serositis (P = 0.004) and a lower cumulative number of SLE manifestations (P = 0.022) compared with the early-onset group. The incidences of all major organ involvement as well as the requirement of immunosuppressive therapies were similar in the two groups. Thus, in this study, late-onset SLE patients had a different clinical profile from the early-onset group, but did not constitute a benign subgroup of the lupus population.

Entities:  

Mesh:

Year:  1998        PMID: 9493145     DOI: 10.1191/096120398678919723

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  16 in total

1.  Late onset lupus nephritis: analysis of clinical manifestations and renal pathological features in Chinese patients.

Authors:  Zheng Tang; Dongmei Chen; Shengmei Yang; Haitao Zhang; Weixin Hu; Zhihong Liu; Leishi Li
Journal:  Rheumatol Int       Date:  2010-06-10       Impact factor: 2.631

Review 2.  Late-onset systemic lupus erythematosus: epidemiology, diagnosis and treatment.

Authors:  Laurent Arnaud; Alexis Mathian; Jacques Boddaert; Zahir Amoura
Journal:  Drugs Aging       Date:  2012-03-01       Impact factor: 3.923

3.  Age of onset influences on clinical and laboratory profile of patients with systemic lupus erythematosus.

Authors:  Rafael Hennemann Sassi; Jordana Vaz Hendler; Giovana Fagundes Piccoli; Andrese Aline Gasparin; Rafael Mendonça da Silva Chakr; João Carlos Tavares Brenol; Odirlei André Monticielo
Journal:  Clin Rheumatol       Date:  2016-11-17       Impact factor: 2.980

4.  Chronic GvHD-associated serositis and pericarditis.

Authors:  J T Leonard; L F Newell; G Meyers; B Hayes-Lattin; J Gajewski; S Heitner; S Nonas; B Allen; A Stentz; R Frires; R T Maziarz; S G Holtan
Journal:  Bone Marrow Transplant       Date:  2015-05-11       Impact factor: 5.483

5.  Disease Expression and HLA Types in Early and Late Onset Disease of Malaysian Patients with Systemic Lupus Erythematosus.

Authors:  A M Radzi; K S Huan; N Yahaya; A Shahera; N Kong; R Mohd Noah
Journal:  Malays J Med Sci       Date:  2001-07

6.  Systemic lupus erythematosus: from genes to organ damage.

Authors:  Vasileios C Kyttaris
Journal:  Methods Mol Biol       Date:  2010

7.  Pulmonary manifestations in late versus early systemic lupus erythematosus: A systematic review and meta-analysis.

Authors:  Jennifer L Medlin; Karen E Hansen; Sara S McCoy; Christie M Bartels
Journal:  Semin Arthritis Rheum       Date:  2018-01-31       Impact factor: 5.532

Review 8.  A systematic review and meta-analysis of cutaneous manifestations in late- versus early-onset systemic lupus erythematosus.

Authors:  Jennifer L Medlin; Karen E Hansen; Sara R Fitz; Christie M Bartels
Journal:  Semin Arthritis Rheum       Date:  2016-01-21       Impact factor: 5.532

Review 9.  Understanding the epidemiology and progression of systemic lupus erythematosus.

Authors:  Guillermo J Pons-Estel; Graciela S Alarcón; Lacie Scofield; Leslie Reinlib; Glinda S Cooper
Journal:  Semin Arthritis Rheum       Date:  2009-01-10       Impact factor: 5.532

10.  Late-onset systemic lupus erythematosus: clinical features, course, and prognosis.

Authors:  Aleksandra Tomic-Lucic; Radmila Petrovic; Marija Radak-Perovic; Dragan Milovanovic; Jasmina Milovanovic; Sandra Zivanovic; Suzana Pantovic; Mirjana Veselinovic
Journal:  Clin Rheumatol       Date:  2013-03-21       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.